PD-Rx Pharmaceuticals Statistics
Total Valuation
PDRX has a market cap or net worth of 4.54 million. The enterprise value is -864,057.
| Market Cap | 4.54M |
| Enterprise Value | -864,057 |
Important Dates
The last earnings date was Friday, December 6, 2024.
| Earnings Date | Dec 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PDRX has 1.64 million shares outstanding. The number of shares has decreased by -6.19% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.64M |
| Shares Change (YoY) | -6.19% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.24 |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.15 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.60 |
Financial Position
The company has a current ratio of 4.97
| Current Ratio | 4.97 |
| Quick Ratio | 3.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6.93% and return on invested capital (ROIC) is -5.47%.
| Return on Equity (ROE) | -6.93% |
| Return on Assets (ROA) | -4.62% |
| Return on Invested Capital (ROIC) | -5.47% |
| Return on Capital Employed (ROCE) | -9.07% |
| Revenue Per Employee | 676,656 |
| Profits Per Employee | -26,911 |
| Employee Count | 28 |
| Asset Turnover | 1.47 |
| Inventory Turnover | 6.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.82% in the last 52 weeks. The beta is 1,210,140.13, so PDRX's price volatility has been higher than the market average.
| Beta (5Y) | 1,210,140.13 |
| 52-Week Price Change | -49.82% |
| 50-Day Moving Average | 5.00 |
| 200-Day Moving Average | 4.22 |
| Relative Strength Index (RSI) | 39.18 |
| Average Volume (20 Days) | 1,927 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, PDRX had revenue of 18.95 million and -753,495 in losses. Loss per share was -0.46.
| Revenue | 18.95M |
| Gross Profit | 5.62M |
| Operating Income | -952,018 |
| Pretax Income | -712,301 |
| Net Income | -753,495 |
| EBITDA | -799,742 |
| EBIT | -952,018 |
| Loss Per Share | -0.46 |
Balance Sheet
The company has 5.40 million in cash and n/a in debt, giving a net cash position of 5.40 million or 3.29 per share.
| Cash & Cash Equivalents | 5.40M |
| Total Debt | n/a |
| Net Cash | 5.40M |
| Net Cash Per Share | 3.29 |
| Equity (Book Value) | 10.50M |
| Book Value Per Share | 6.38 |
| Working Capital | 9.06M |
Cash Flow
In the last 12 months, operating cash flow was -1.35 million and capital expenditures -77,934, giving a free cash flow of -1.43 million.
| Operating Cash Flow | -1.35M |
| Capital Expenditures | -77,934 |
| Free Cash Flow | -1.43M |
| FCF Per Share | -0.87 |
Margins
Gross margin is 29.68%, with operating and profit margins of -5.02% and -3.98%.
| Gross Margin | 29.68% |
| Operating Margin | -5.02% |
| Pretax Margin | -3.76% |
| Profit Margin | -3.98% |
| EBITDA Margin | -4.22% |
| EBIT Margin | -5.02% |
| FCF Margin | n/a |
Dividends & Yields
PDRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.19% |
| Shareholder Yield | 6.19% |
| Earnings Yield | -16.60% |
| FCF Yield | -31.48% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PDRX has an Altman Z-Score of 5.68.
| Altman Z-Score | 5.68 |
| Piotroski F-Score | n/a |